research product . 2020

Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19

Magagnoli, Joseph et al.;
Open Access English
  • Published: 23 Apr 2020
BACKGROUND: Despite limited and conflicting data on the use of hydroxychloroquine in patients with Covid-19, the U.S. Food and Drug Administration has authorized the emergency use of this drug when clinical trials are unavailable or infeasible. Hydroxychloroquine, alone or in combination with azithromycin, is being widely used in Covid-19 therapy based on anecdotal and limited observational evidence. METHODS: We performed a retrospective analysis of data from patients hospitalized with confirmed SARS-CoV-2 infection in all United States Veterans Health Administration medical centers until April 11, 2020. Patients were categorized based on their exposure to hydro...
Persistent Identifiers
free text keywords: COVID-19, Coronavirus, Hydroxychloroquine, United States, Veterans, Hospitalization, Azithromycin
  • COVID-19
Any information missing or wrong?Report an Issue